November 2021 Issue Table Of Contents

From The Editor

• Let Us Give Thanks

Feature Articles

• Jaguar Health’s Lisa Conte — An Entrepreneurial Ascent Like No Other

CEO Corner

• Is It A Great Business Opportunity Or Merely A Great Idea?

Companies To Watch

• Graphite Bio

Industry Research

• Managing Trial Components: Hybrid Vs. Traditional Models

Inside The Industry

• Not Your Father’s Blockchain
• Beat The Breakthrough Therapy Designation Dearth
• What Kind Of Commercial Space Does Your Lab Really Require?
• A Dynamic Supply Chain Can Help Biopharmas Survive And Thrive
• U.S. Biopharma Manufacturing: Not An Overhead Cost But A Value Center!
• Why Korea Is Now More Attractive To U.S. Biopharma
• The Lasting Impact Of The Pandemic On Pharmacovigilance
• From SPAC To De-SPAC, A Tutorial From A CFO: Part 2
• Long Hauler In The Antibiotics Space
• Turbocharging Early-Stage Biotech Growth With Venture Debt
• Hire Like A Candidate: Courtesy Is Your Differentiator

Leadership Lessons

• Just Four Words

Ask The Board

• How Did The Pandemic Impact You As An Executive?
• What Were Some Insights You Gained From Working As A Biopharma Manufacturing Exec During The Pandemic?
• What Was The Biggest Insight You Gained From Working As A Biopharma Manufacturing Exec During The Pandemic?